Verheijen JH - Search Results

1

Local treatment of venous ulcers with tissue type plasminogen activator containing ointment.

Zeegelaar JE, Verheijen JH, Kerckhaert JA, Jankowski I, Faber WR. Zeegelaar JE, et al. Among authors: verheijen jh. Vasa. 1997 May;26(2):81-4. Vasa. 1997. PMID: 9174382

2

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.

Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. Kluft C, et al. Among authors: verheijen jh. Scand J Clin Lab Invest. 1985 Nov;45(7):605-10. doi: 10.3109/00365518509155267. Scand J Clin Lab Invest. 1985. PMID: 3934744

3

Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.

Boxman IL, Quax PH, Löwik CW, Papapoulos SE, Verheijen J, Ponec M. Boxman IL, et al. J Invest Dermatol. 1995 Mar;104(3):374-8. doi: 10.1111/1523-1747.ep12665844. J Invest Dermatol. 1995. PMID: 7861005 Free article.

4

Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor.

D'Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM. D'Angelo A, et al. Among authors: verheijen jh. Eur J Clin Invest. 1985 Dec;15(6):308-12. doi: 10.1111/j.1365-2362.1985.tb00277.x. Eur J Clin Invest. 1985. PMID: 3938400

5

Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).

Kluft C, Jie AF, Rijken DC, Verheijen JH. Kluft C, et al. Among authors: verheijen jh. Thromb Haemost. 1988 Apr 8;59(2):329-32. Thromb Haemost. 1988. PMID: 3133814

6

Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin.

Padró T, Quax PH, van den Hoogen CM, Roholl P, Verheijen JH, Emeis JJ. Padró T, et al. Among authors: verheijen jh. Arterioscler Thromb. 1994 Sep;14(9):1459-65. doi: 10.1161/01.atv.14.9.1459. Arterioscler Thromb. 1994. PMID: 8068608

7

The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells.

Mulder M, Kohnert U, Fischer S, van Hinsbergh VW, Verheijen JH. Mulder M, et al. Among authors: verheijen jh. Blood Coagul Fibrinolysis. 1997 Mar;8(2):124-33. doi: 10.1097/00001721-199703000-00007. Blood Coagul Fibrinolysis. 1997. PMID: 9518044

8

Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.

Verheijen JH, Caspers MP, Chang GT, de Munk GA, Pouwels PH, Enger-Valk BE. Verheijen JH, et al. EMBO J. 1986 Dec 20;5(13):3525-30. doi: 10.1002/j.1460-2075.1986.tb04678.x. EMBO J. 1986. PMID: 3030730 Free PMC article.

9

The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot.

Bakker AH, Weening-Verhoeff EJ, Verheijen JH. Bakker AH, et al. Among authors: verheijen jh. J Biol Chem. 1995 May 26;270(21):12355-60. doi: 10.1074/jbc.270.21.12355. J Biol Chem. 1995. PMID: 7759476 Free article.

10

Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor- and kringle 1-domains.

Emeis JJ, Verheijen JH. Emeis JJ, et al. Among authors: verheijen jh. Ann N Y Acad Sci. 1992 Dec 4;667:421-3. doi: 10.1111/j.1749-6632.1992.tb51642.x. Ann N Y Acad Sci. 1992. PMID: 1309064 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters